Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

216
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
216
Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

476
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
476
Skeletal Muscle Relaxants: Adverse Effects01:21

Skeletal Muscle Relaxants: Adverse Effects

335
Skeletal muscle relaxants are widely used for muscle paralysis and relieving pain following any muscle injury or stiffness. However, depending on the drug type, they can have adverse effects that range from mild to severe. Usually, nondepolarizing neuromuscular blockers have minimal side effects. For example, drugs like d-tubocurarine, cisatracurium, and rocuronium cause hypotension, whereas drugs like baclofen, when stopped abruptly, can lead to the recurrence of spastic conditions.
Unlike...
335
Lysosomal Hydrolases01:22

Lysosomal Hydrolases

3.8K
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
3.8K
Indirect-Acting Cholinergic Agonists: Pharmacological Actions01:30

Indirect-Acting Cholinergic Agonists: Pharmacological Actions

614
Indirect-acting cholinergic agonists, also known as anticholinesterases, exert their pharmacological effects by enhancing cholinergic transmission in various body parts, including the neuromuscular junction, autonomic cholinergic synapses, and the brain.
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
614

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Optimization of Preclinical Rodent Research Models of Human Shock: Part 2 Trauma, Burn, and the Gut Microbiome.

Shock (Augusta, Ga.)·2026
Same author

Hybrid constitutive law with machine learning for sintering of advanced ceramics.

Scientific reports·2026
Same author

340B Drug Pricing Program: An Updated ASCO Policy Statement.

JCO oncology practice·2026
Same author

A qPCR method for detection of 'Candidatus Liberibacter asiaticus': Optimization of selected assay parameters.

Journal of microbiological methods·2026
Same author

Persistent inflammation, immunosuppression, and catabolic syndrome: A new look at a growing problem.

Nutrition in clinical practice : official publication of the American Society for Parenteral and Enteral Nutrition·2026
Same author

Psychopathology distinguishing secondary ("organic") psychoses: A systematic review and meta-analysis.

Schizophrenia research·2026

Related Experiment Video

Updated: Jun 5, 2025

Treating SCA1 Mice with Water-Soluble Compounds to Non-Specifically Boost Mitochondrial Function
11:47

Treating SCA1 Mice with Water-Soluble Compounds to Non-Specifically Boost Mitochondrial Function

Published on: January 22, 2017

10.5K

Carnitine supplementation in progressive supranuclear palsy.

Devika Dixit1, Yang Zhao2, Olgert Bardhi3

  • 1Department of Internal Medicine, University of Florida, Gainesville, Florida, USA.

Nutrition in Clinical Practice : Official Publication of the American Society for Parenteral and Enteral Nutrition
|December 15, 2024
PubMed
Summary

This case report highlights that carnitine supplementation may improve symptoms in progressive supranuclear palsy (PSP). A patient with PSP and carnitine deficiency showed significant symptom improvement after levocarnitine treatment.

Keywords:
adultcarnitine deficiencyenteral accessenteral formulasenteral nutritiongastroenterologyminerals/trace elementsnutrition support teamsparenteral nutrition

More Related Videos

Utility of Dissociated Intrinsic Hand Muscle Atrophy in the Diagnosis of Amyotrophic Lateral Sclerosis
08:16

Utility of Dissociated Intrinsic Hand Muscle Atrophy in the Diagnosis of Amyotrophic Lateral Sclerosis

Published on: March 4, 2014

31.7K
Author Spotlight: Establishing a New Fluorescence-Based Protocol for In Vivo Mitochondrial Morphology Analysis in Parkinson's Disease
06:07

Author Spotlight: Establishing a New Fluorescence-Based Protocol for In Vivo Mitochondrial Morphology Analysis in Parkinson's Disease

Published on: June 23, 2023

1.5K

Related Experiment Videos

Last Updated: Jun 5, 2025

Treating SCA1 Mice with Water-Soluble Compounds to Non-Specifically Boost Mitochondrial Function
11:47

Treating SCA1 Mice with Water-Soluble Compounds to Non-Specifically Boost Mitochondrial Function

Published on: January 22, 2017

10.5K
Utility of Dissociated Intrinsic Hand Muscle Atrophy in the Diagnosis of Amyotrophic Lateral Sclerosis
08:16

Utility of Dissociated Intrinsic Hand Muscle Atrophy in the Diagnosis of Amyotrophic Lateral Sclerosis

Published on: March 4, 2014

31.7K
Author Spotlight: Establishing a New Fluorescence-Based Protocol for In Vivo Mitochondrial Morphology Analysis in Parkinson's Disease
06:07

Author Spotlight: Establishing a New Fluorescence-Based Protocol for In Vivo Mitochondrial Morphology Analysis in Parkinson's Disease

Published on: June 23, 2023

1.5K

Area of Science:

  • Neuroscience
  • Mitochondrial Biology
  • Nutritional Science

Background:

  • Mitochondrial dysfunction is linked to neurodegenerative diseases like progressive supranuclear palsy (PSP).
  • Carnitine is crucial for mitochondrial energy production.
  • PSP is a severe Parkinsonian syndrome with limited treatment options.

Purpose of the Study:

  • To report the first case of carnitine supplementation in a patient with progressive supranuclear palsy.
  • To investigate the potential benefits of carnitine repletion in managing PSP symptoms.

Main Methods:

  • A 65-year-old male patient with PSP and malnutrition was diagnosed with carnitine deficiency.
  • The patient received levocarnitine supplementation.
  • Clinical symptoms and physical therapy progress were monitored.

Main Results:

  • Levocarnitine supplementation led to marked improvement in the patient's tremors, fatigue, and physical function.
  • Sustained symptom improvement was observed with continued supplementation post-hospitalization.

Conclusions:

  • Carnitine repletion may be a beneficial supportive therapy for progressive supranuclear palsy.
  • Further research is needed to understand the role of carnitine in PSP pathophysiology and explore other nutritional interventions.